Tumor response like pseudo-progression to lenvatinib in advanced thymic carcinoma

Lung Cancer. 2023 May:179:107193. doi: 10.1016/j.lungcan.2023.107193. Epub 2023 Apr 10.

Authors

Koki Ito¹, Ou Yamaguchi¹, Kyoichi Kaira², Hisao Imai¹, Hiroshi Kagamu¹

Affiliations

¹ Department of Respiratory Medicine, International Medical Center, Saitama Medical University, Japan.
² Department of Respiratory Medicine, International Medical Center, Saitama Medical University, Japan. Electronic address: kkaira1970@yahoo.co.jp.

PMID: 37058785
DOI: 10.1016/j.lungcan.2023.107193

No abstract available

Keywords: Pseudo-progression; Response; Thymic carcinoma; Tumor necrosis.

Publication types

Letter

MeSH terms

Humans
Liver Neoplasms*
Lung Neoplasms*
Phenylurea Compounds
Quinolines*
Thymoma*
Thymus Neoplasms* / pathology

Substances

lenvatinib
Phenylurea Compounds
Quinolines